Star InactiveStar InactiveStar InactiveStar InactiveStar Inactive

Most of the focus of this blog is generally on the pharmaceutical side of the business related to cold chain, supply chain and the management of temperature controlled drug related products.

1 1 1 1 1 1 1 1 1 1

Peter Norton is a senior logistics and supply chain manager and consultant to the life science industry, with extensive experience in both the domestic US and global markets.

Peter's Recent Articles

Star InactiveStar InactiveStar InactiveStar InactiveStar Inactive

Reading many of the latest comments and articles from the EU it appears that compliance audits have already started in earnest by the regulatory authorities now that the implementation period is well over (6 months from March 2013).

1 1 1 1 1 1 1 1 1 1

Peter Norton is a senior logistics and supply chain manager and consultant to the life science industry, with extensive experience in both the domestic US and global markets.

Peter's Recent Articles

Star InactiveStar InactiveStar InactiveStar InactiveStar Inactive

Within the global logistics supply chain the transportation of cold chain products is generally very highly regulated, with GMP, GDP or even GSP regulations.

5 1 1 1 1 1 1 1 1 1 1

Peter Norton is a senior logistics and supply chain manager and consultant to the life science industry, with extensive experience in both the domestic US and global markets.

Peter's Recent Articles

Star InactiveStar InactiveStar InactiveStar InactiveStar Inactive

I am sure that most of the Blog readers are familiar with MKT (Mean Kinetic Temperature) calculations, but just in case you are not, MKT is defined by the United States Pharmacopeia as:

1 1 1 1 1 1 1 1 1 1

Peter Norton is a senior logistics and supply chain manager and consultant to the life science industry, with extensive experience in both the domestic US and global markets.

Peter's Recent Articles

Star InactiveStar InactiveStar InactiveStar InactiveStar Inactive

Last Wednesday (March 12th) we held our webinar related to new and global supply chain regulations and Risk Assessment and Risk Planning. This webinar was well attended and the majority of those individuals that had registered did attend and listened to the webinar.

1 1 1 1 1 1 1 1 1 1

Peter Norton is a senior logistics and supply chain manager and consultant to the life science industry, with extensive experience in both the domestic US and global markets.

Peter's Recent Articles

Star InactiveStar InactiveStar InactiveStar InactiveStar Inactive

In a recent Blog post I discussed two recent regulations that were introduced last year, one for GDP (Good Distribution Practices) within the EU and one for GSP (Good Supply Practices) within China.

1 1 1 1 1 1 1 1 1 1

Peter Norton is a senior logistics and supply chain manager and consultant to the life science industry, with extensive experience in both the domestic US and global markets.

Peter's Recent Articles

Star InactiveStar InactiveStar InactiveStar InactiveStar Inactive

On November 27th of 2013 when President Obama signed into law the HR3204 - the Drug Quality and Security Act, it was the result of many years of discussion and past attempts to establish a US centric law based upon securing the drug supply chain in an effort to prevent the entry of falsified medicinal products into the supply chain.

1 1 1 1 1 1 1 1 1 1

Peter Norton is a senior logistics and supply chain manager and consultant to the life science industry, with extensive experience in both the domestic US and global markets.

Peter's Recent Articles